News

Investing.com -- Circle Internet Group, Inc. (NYSE: CRCL) reported first-quarter fiscal 2026 results that beat earnings expectations but fell short on revenue, sending shares down 3% premarket following the announcement.

The pace of first quarter earnings reports eases this week as economic data takes center stage, but investors will still be on the lookout for results from a handful of big corporations.

Healthcare stocks have had a rough stretch. Rising medical costs, Medicaid pressure, and persistent skepticism about managed care margins have kept investors on edge all year. Walking into a CVS Health earnings report in that environment felt like bracing for bad news. The bad news, however, didn't ...

NRG Energy Inc. (NYSE:NRG) is one of the high growth utility stocks to buy according to analysts. On May 5, NRG Energy Inc. (NYSE:NRG) reiterated that demand for its product continues to grow despite a significant decrease in earnings in the first quarter. Net income fell by $625 million to $125 million, attributed to unrealized […]

Qualcomm says the company has a growing opportunity in data.

Probably. Capital One's issues are not an isolated problem.

Klaviyo delivers cloud-based marketing automation tools to businesses worldwide, powering personalized digital communications at scale.

On May 8, 2026, investors weighed ad-tech growth against margin pressure, cautious guidance, and fresh Wall Street downgrades.

Strategy is evolving into a leveraged Bitcoin play layered with rising income features, leaving investors to weigh extreme volatility against Wall Street’s 'Strong Buy' consensus.

You know that feeling when you've been backing a friend's idea for months, and then suddenly the whole room starts paying attention? That's roughly where Morgan Stanley finds itself with Advanced Micro Devices (AMD). For the better part of six months, the firm had been quietly bullish on AMD's ...

Fluor (FLR) reported weaker-than-expected first-quarter results on Friday while the engineering and

Cloudflare (NYSE:NET) reported first-quarter 2026 results on May 7, beating analyst expectations for both revenue and earnings, but shares fell sharply after the company issued softer near-term guidance and announced a significant restructuring tied to an AI-focused operating model...

EMBJ misses Q1 earnings estimates, but revenues jump 31% year over year as jet deliveries and backlog showed strong growth.

Fluor Corporation (NYSE:FLR) shares dropped 5. 05% in premarket trading on Friday after the engineering and construction company reported weaker-than-expected first-quarter results and tightened its full-year outlook.

Cloudfare issued a Q2 sales forecast on Thursday that fell short of analyst expectations and said it would slash roughly 1,100 jobs, or about a fifth of its workforce, as it adopts artificial intelligence tools in its operating model.

Shares of The Trade Desk (NASDAQ:TTD) are down roughly 13% to $20.41 in early Friday trading after the company posted a Q1 2026 earnings miss and issued a softer Q2 2026 outlook than the Street had hoped to see. The stock closed Thursday at $23.49, already down 38% year to date (YTD) heading into the ... Trade Desk Tumbles 13%, AppLovin Holds Gains as Ad-Tech Q1 Earnings Split Wall Street

Lyft revenues rise 13.8% in Q1 as gross bookings climb 19%, though earnings miss estimates and cash balances decline.

The Japanese entertainment and electronics company has spent billions of dollars on acquisitions in recent years to beef up its entertainment content.

The AI cloud company topped first-quarter revenue estimates but its second-quarter outlook trailed Wall Street expectations, and it raised the low end of its 2026 capital spending forecast

Enbridge (ENB.TO)'s earnings declined year over year in the first quarter, the company said Friday,

(Updates to include restructuring details and the latest stock price movement.) Cloudflare (NET)

Q1 earnings trigger fresh questions for Trade Desk (TTD) Trade Desk (TTD) reported first quarter 2026 results with sales of US$688.86 million and net income of US$40 million, while issuing guidance below market expectations for the next quarter. The mix of revenue growth, lower earnings per share versus a year earlier and softer forward guidance, together with new partnerships and data oversight scrutiny, gives investors several factors to consider with this stock. See our latest analysis for...

Dropbox (DBX) delivered earnings and revenue surprises of +7.04% and +1.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Investing.com -- Motorola Solutions Inc (NYSE:MSI) reported first-quarter results that exceeded analyst expectations, but shares fell 2.1% in after-hours trading Thursday as investors appeared underwhelmed by the company's second-quarter earnings outlook.

Investing.com -- MercadoLibre Inc (NASDAQ:MELI) reported first quarter results that missed earnings expectations despite strong revenue growth, sending shares down 7.2% in after-hours trading Thursday.

Option Care Health provides infusion therapies and clinical support nationwide, focusing on complex care beyond traditional hospitals.

Cloudflare stock was falling sharply in late Thursday despite better-than-expected first-quarter results from the cybersecurity company. Cloudflare reported adjusted earnings of 25 cents a share on revenue of $639.8 million. Analysts surveyed by FactSet were expecting earnings of 23 cents a share on revenue of $621 million.

Airbnb (ABNB) delivered earnings and revenue surprises of -15.23% and +2.16%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Thursday, MP reported first-quarter earnings per share of 3 cents from sales of $90.6 million. Wall Street was looking for a loss of 3 cents from sales of closer to $75 million.

Gilead Sciences beat analysts’ earnings and revenue expectations in its latest quarter. Gilead logged adjusted earnings of $2.03 a share, ahead of the $1.91 consensus among analysts polled by FactSet. Gilead’s top-line growth rested heavily on Biktarvy, its blockbuster HIV treatment, which accounted for nearly half of total revenue as sales rose 8% to $3.4 billion.